EUROGENETIC

NEW NIPT TEST

The first non-invasive prenatal test that analyzes the entire fetal genome

(OVER 20,000 GENES)

Compared to traditional NIPT, it demonstrated superior sensitivity and specificity, resulting in a significant reduction in false positives (40 vs 11) and false negatives (2 vs 0). The sensitivity of the test reached 100%

(vs. 98.4% for traditional NIPT test)



Unlike traditional NIPT tests, which due to their low resolution focus exclusively on the detection of aneuploidies and structural chromosomal abnormalities, Genome offers a technologically advanced solution.

In addition to detecting common and rare fetal aneuploidies, deletions, duplications, and microdeletion/microduplication syndromes, the test allows screening for ~7,000 serious and clinically known genetic diseases, both inherited and de novo.

This is possible thanks to high-resolution sequencing of the entire protein-coding fetal genome (exome), which includes more than 20,000 genes.

Genome's Plus level also includes a carrier screening test for both parents to assess carrier status for gene mutations associated with ~7,000 genetic diseases.

beyond:

Most common chromosomal aneuploidies Trisomy 21 Trisomy 18 Trisomy 13 Monosomy X XXX XXY XYY Other less frequent chromosomal aneuploidies Trisomy 1 Trisomy 5 Trisomy 9* Trisomy 14 Trisomy 19 Trisomy 2 Trisomy 6 Trisomy 10 Trisomy 15 Trisomy 20 Trisomy 3 Trisomy 7 Trisomy 11 Trisomy 16* Trisomy 22* Trisomy 4 Trisomy 8 Trisomy 12 Trisomy 17